Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Telmisartan/HCTZ FDC vs Monocomponents
NCT02176512Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 1998
- Primary completion
- Oct 1998
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma concentration-time curve from time zero to infinity, Maximum drug plasma concentration and 1 more. Started Sep 1998; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02176512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176512.